Why Eczema Itches So Much, Understanding the Itch–Inflammation Cycle

For people living with eczema, itch is often the most distressing symptom. It disrupts sleep, drives scratching, worsens skin damage, and can feel impossible to control. While itch is often treated as a secondary symptom, science tells a different story.

In eczema, itch is not just a reaction to inflamed skin, it is a central driver of disease activity.

The Immune System and the Itch Signal

Eczema is associated with immune signaling patterns that favor inflammation, particularly pathways involving Th2 immune responses. These immune pathways release cytokines that directly activate itch-specific nerve fibers in the skin¹.

One of the most important itch-related cytokines is interleukin-31 (IL-31). IL-31 binds directly to receptors on sensory nerves, sending powerful itch signals to the brain². This means itch can occur even before visible redness or rash appears.

Scratching Fuels the Fire

Scratching provides temporary relief, but it mechanically damages the skin barrier. This damage:

• Increases water loss from the skin
• Allows microbes and irritants to penetrate more easily
• Triggers additional immune activation

As the barrier weakens, immune signaling intensifies, leading to more IL-31 release and stronger itch signals. This creates the classic itch–scratch cycle that makes eczema so persistent.

Why Itch Often Worsens at Night

Many people notice eczema itch is worse at night. Several factors contribute:

• Natural nighttime drops in cortisol, the body’s anti-inflammatory hormone
• Increased skin dryness during sleep
• Reduced distractions, making itch signals more noticeable

Sleep disruption further worsens immune regulation, creating a feedback loop between poor sleep and worsening eczema³.

Putting It All Together

In eczema, itch is not just a symptom, it is a disease amplifier. Calming immune signaling, supporting barrier repair, and breaking the itch–scratch cycle are essential for long-term improvement.

References

1. Guttman-Yassky E, et al. Atopic dermatitis: molecular pathogenesis and emerging therapies. J Allergy Clin Immunol. 2018.
2. Dillon SR, et al. Interleukin-31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol.2004.
3. Silverberg JI. Sleep disturbances in patients with eczema. Ann Allergy Asthma Immunol. 2015.